Clinical Trial Update: Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluating the abuse potential, safety, and likeability of NRP 104 in adults with histories of stimulant use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amphetamine Use Disorder
• Attention Deficit Hyperactivity Disorder
• Substance Use Disorder

Drugs mentioned

• NRP 104

Snippet

Sponsor: New River Pharmaceuticals | Conditions: Attention Deficit Disorder With Hyperactivity, Amphetamine-Related Disorders | Phase 1, Phase 2 | Status: COMPLETED